<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04006782</url>
  </required_header>
  <id_info>
    <org_study_id>FIBEA_02_EC_19_Estrechos</org_study_id>
    <nct_id>NCT04006782</nct_id>
  </id_info>
  <brief_title>Narrow Dental Implants in Multiple Fixed Prosthesis: A Controlled Clinical Trial</brief_title>
  <official_title>Narrow Dental Implants in Multiple Fixed Prosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Eduardo Anitua</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BTI S.L</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundación Eduardo Anitua</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the survival of narrow dental implants (≤ 3,5 mm)
      in multiple fixed prostheses in comparison with standard diameter dental implants (≥ 3,75 mm)
      after 5 years of follow-up. The hypothesis of the study is that narrow dental implants under
      the evaluated conditions, have the same survival rate and clinical performance than the
      standard diameter implants.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival after 5 years of follow-up</measure>
    <time_frame>5 years in comparison with the baseline</time_frame>
    <description>Implant survival after 5 years of follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Marginal Bone Loss</measure>
    <time_frame>1, 3 and 5 years in comparison with the baseline</time_frame>
    <description>Evolution of the peri-implant bone level along the study follow up</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Edentulous Alveolar Ridge</condition>
  <arm_group>
    <arm_group_label>Narrow dental implants in multiple fixed prosthesis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Narrow dental implants</intervention_name>
    <description>Insertion of narrow dental implants in multiple fixed prosthesis</description>
    <arm_group_label>Narrow dental implants in multiple fixed prosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of legal age (&gt;18 years) of both sexes.

          -  Clinical need of multiple fixed alveolar ridge rehabilitations.

          -  Clinical suitability to insert, at least, one narrow dental implant splinted to a
             standard diameter dental implant.

          -  Signature of the informed consent

        Exclusion Criteria:

          -  Presence of an active infection

          -  Being under active treatment with, or have received in the las 30 days treatment with
             radiotherapy, chemotherapy, immunosuppressors, systemic corticosteroids and/or
             anticoagulants.

          -  Presence of severe haematologic disorders.

          -  Chronic treatment with non steroidal anti-inflammatory drugs (NSAID) or other
             aniinflammatory drugs.

          -  Previous diagnosis of chronic hepatitis or liver cirrhosis.

          -  Presence of Diabetes mellitus with improper metabolic control (glycosylated
             haemoglobine higher that 9%).

          -  Patients subjected to dialysis.

          -  Presence of malignant tumours, haemangioma or angioma in the surgical area.

          -  History of ischaemic cardiopathy in the las year.

          -  Pregnancy or plan to getting pregnant during the study.

          -  Metabolic bone disease

          -  Patientd receiving treatment with oral or intravenous biphosphonates.

          -  Any other condition incompatible with the participation in the study,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eduardo Anitua, MD, DDS, PhD</last_name>
    <email>eduardoanitua@eduardoanitua.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clínica Dental Eduardo Anitua</name>
      <address>
        <city>Vitoria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Anitua, MD, DDS, PhD</last_name>
      <email>eduardoanitua@eduardoanitua.com</email>
    </contact>
    <investigator>
      <last_name>Eduardo Anitua, MD, DDS, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>August 2, 2019</last_update_submitted>
  <last_update_submitted_qc>August 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>edentulous</keyword>
  <keyword>narrow alveolar ridges</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth, Edentulous</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

